ChitogenX Inc. (CSE: CHGX)
Canada
· Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Dec 2, 2024, 9:30 AM EST
ChitogenX Statistics
Total Valuation
ChitogenX has a market cap or net worth of CAD 415,648. The enterprise value is 4.53 million.
Market Cap | 415,648 |
Enterprise Value | 4.53M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ChitogenX has 83.13 million shares outstanding. The number of shares has increased by 43.02% in one year.
Current Share Class | n/a |
Shares Outstanding | 83.13M |
Shares Change (YoY) | +43.02% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 16.85% |
Owned by Institutions (%) | n/a |
Float | 45.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.62 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
Current Ratio | 0.02 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1.73 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -141.85% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.00% in the last 52 weeks. The beta is -0.04, so ChitogenX's price volatility has been lower than the market average.
Beta (5Y) | -0.04 |
52-Week Price Change | -95.00% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 41.50 |
Average Volume (20 Days) | 95,457 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.31M |
Pretax Income | -1.73M |
Net Income | -1.73M |
EBITDA | -1.27M |
EBIT | -1.31M |
Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 12,000 in cash and 4.13 million in debt, giving a net cash position of -4.12 million or -0.05 per share.
Cash & Cash Equivalents | 12,000 |
Total Debt | 4.13M |
Net Cash | -4.12M |
Net Cash Per Share | -0.05 |
Equity (Book Value) | -6.77M |
Book Value Per Share | -0.08 |
Working Capital | -6.94M |
Cash Flow
Operating Cash Flow | -484,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ChitogenX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -43.02% |
Shareholder Yield | -43.02% |
Earnings Yield | -420.08% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |